New aromatase inhibitors: More selectivity, less toxicity, unfortunately, the same activity

被引：23

作者：

CastiglioneGertsch, M

机构：

来源：

关键词：

D O I：

10.1016/0959-8049(95)00013-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：393 / 395

页数：3

共 20 条

[1] Beatson G.T., 1896, LANCET, V148, P162, DOI DOI 10.1016/S0140-6736(01)72384-7
[2] Beatson GT., 1896, LANCET, V148, P104, DOI DOI 10.1016/S0140-6736(01)72307-0
[3] 2ND LINE HORMONAL-THERAPY WITH AMINOGLUTETHIMIDE IN METASTATIC BREAST-CANCER
BRUFMAN, G
BIRAN, S
[J]. ACTA ONCOLOGICA, 1990, 29 (06) : 717 - 720
[4] AROMATASE INHIBITORS IN HUMAN-BREAST CANCER
COOMBES, RC
STEIN, RC
DOWSETT, M
[J]. PROCEEDINGS OF THE ROYAL SOCIETY OF EDINBURGH SECTION B-BIOLOGICAL SCIENCES, 1989, 95 : 283 - 291
[5] ENDOGENOUS OESTRADIOL-17-BETA CONCENTRATION IN BREAST-TUMORS DETERMINED BY MASS FRAGMENTOGRAPHY AND BY RADIOIMMUNOASSAY - RELATIONSHIP TO RECEPTOR CONTENT
EDERY, M
GOUSSARD, J
DEHENNIN, L
SCHOLLER, R
REIFFSTECK, J
DROSDOWSKY, MA
[J]. EUROPEAN JOURNAL OF CANCER, 1981, 17 (01) : 115 - 120
[6] GOSS PE, 1995, CLIN CANCER RES, V1, P287
[7] HOFFKEN K, 1990, J CLIN ONCOL, V8, P875
[8] HONIG SF, 1996, DISEASES BREAST, P685
[9] A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (ARIMIDEX) with megestrol acetate in postmenopausal patients with advanced breast cancer
Jonat, W
Howell, A
Blomqvist, C
Eiermann, W
Winblad, G
Tyrrell, C
Mauriac, L
Roche, H
Lundgren, S
Hellmund, R
Azab, M
[J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) : 404 - 412
[10] LIPTON A, 1995, CANCER, V75, P2132, DOI 10.1002/1097-0142(19950415)75:8<2132::AID-CNCR2820750816>3.0.CO